Resonance Health Limited Resonance Health Limited

Resonance Health Limited

RHT

Rank in Stocks #24787
Resonance Health Limited is a global provider of healthcare technology and... Resonance Health Limited is a global provider of healthcare technology and services, specializing in the design, development, and production of software-as-medical devices. The company serves markets across the Asia Pacific, Americas, Europe, Middle East, and Africa. Its portfolio of non-invasive, MRI-based diagnostic tools includes FerriScan, a system for quantifying liver iron concentration (LIC); FerriSmart, leveraging artificial intelligence (AI) for automated, real-time assessment of LIC; HepaFat-AI, an AI-driven solution for real-time, multi-metric liver fat quantification; CardiacT2, which provides dual analysis in conjunction with FerriScan to evaluate cardiac iron accumulation; HepaFat-Scan, a non-invasive MRI method for assessing liver fat within tissue; and LiverSmart, a comprehensive non-invasive MRI device integrating FerriSmart and HepaFat-AI for a unified report. The company further extends its offerings to include quantitative imaging measurements and Contract Research Organization (CRO) services, encompassing rigorous image analysis, imaging charter development, robust project and data management, proactive issue resolution, site tracking with clinical trial progress reports, and streamlined data flow coordination. They also provide comprehensive biomarker services, covering analysis of blood, urine, and protein analytes, alongside RNA, DNA, and genotyping. Their support for multinational and multicenter clinical trials extends to protocol development, subject inclusion/exclusion criteria assessment, dose modification strategies, new therapy safety profile evaluations, and establishing primary and secondary endpoints for drug efficacy. Additionally, they supply phantoms crucial for MRI machine calibration. Its client base includes clinicians, who utilize their solutions for managing human diseases, and pharmaceutical and therapeutic companies engaged in clinical research. Established in 1987, Resonance Health Limited maintains its headquarters in Burswood, Australia.
Share Price
$0.06260782
Last synced: 2026-11-13
Market Cap
$29.82M
Change (1 day)
1.64%
Change (1 year)
100.79%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Resonance Health Limited (RHT)
EPS as of June 2026 TTM: $0.00
According to Resonance Health Limited's latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Resonance Health Limited from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) 0.00 -933.33%
2025 0.00 -933.33%
2024 0.00 -127.27%
2023 0.00 -35.29%
2022 0.00 -270.00%
2021 0.00 -183.33%
2020 0.00 -154.55%
2019 0.00 450.00%
2018 0.00 -166.67%
2017 0.00 -14.29%
2016 0.00 -177.78%
2015 0.00 -550.00%
2014 0.00 -60.00%
2013 0.00 -28.57%
2012 0.00 -30.00%
2011 0.00 233.33%
2010 0.00 -121.43%
2009 0.00 -1,500.00%
2008 0.00 -94.74%
2007 0.00 -96.42%
2006 $-0.05 295.52%
2005 $-0.01 -294.20%
2004 $0.01 -91.43%
2003 $0.08 -128.58%
2002 $-0.28 -621.67%
2000 $0.05 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$4.74 215,354.55%
US
$1.64 74,445.45%
US
$1.72 78,072.73%
AU
$-1.05 -47,827.27%
US
$2.08 94,445.45%
US

Questions about Resonance Health Limited's earnings per share (EPS)

What is Resonance Health Limited's earnings per share (EPS)?

Resonance Health Limited's earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.

What was Resonance Health Limited's earnings per share (EPS) in 2025?

In 2025, Resonance Health Limited's earnings per share (EPS) was 0.00, compared with 0.00 in 2024.

How has Resonance Health Limited's earnings per share (EPS) changed since 2020?

From 2020 to 2025, Resonance Health Limited's earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).

How does Resonance Health Limited's earnings per share (EPS) compare with similar companies?

Resonance Health Limited's earnings per share (EPS) ($0.00) is higher than that of 1 of the 5 similar companies listed above. The highest among them is GE HealthCare Technologies Inc., with $4.74.